Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10941672

Evolution of solid-phase microextraction technology.

H Lord·J Pawliszyn
View original source ↗Export metadata ↓

Abstract

The main objective of this contribution is to describe the development of the concepts, techniques and devices associated with solid-phase microextraction, as a response to the evolution of understanding of the fundamental principles behind this technique. The discussion begins with an historical perspective on the very early work conduced almost a decade ago. As new fundamental understanding about the functioning of the technology developed, new ways of constructing and using the SPME devices evolved.

Explore related subjects

Chromatography, LiquidJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Lord, J Pawliszyn. 2000-07-14. Evolution of solid-phase microextraction technology.. https://doi.org/10.1016/s0021-9673(00)00535-5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Relationship of melanin degradation products to actual melanin content: application to human hair.

Methods not only for characterizing but also for quantitating melanin subtypes from the two types of melanin found in hair--eumelanin and pheomelanin--have been established. In relation to testing for drugs of abuse in hair, these methods will allow for correction of drug binding to specific melanin subtypes and will serve to improve drug measurement in hair. 5,6-Dihydroxyindole (DHI) and 5,6-dihydroxyindole-2-carboxylic acid (DHICA) make up the majority of the eumelanin polymer while benzothiazene units derived from 2-cysteinyl-S-Dopa (2-CysDopa) and 5-cysteinyl-S-Dopa (5-CysDopa) compose the majority of the pheomelanin polymer. Our results show that: (1) pyrrole-2,3-dicarboxylic acid (PDCA) and pyrrole-2,3,5-tricarboxylic acid (PTCA), markers for DHI and DHICA units, respectively, are produced in 0.37 and 4.8% yields, respectively, when melanins are subjected to alkaline hydrogen peroxide degradation, (2) 3-aminotyrosine (3AT) and 4-amino-3-hydroxyphenylalanine (AHP), markers for 2-CysDopa and 5-CysDopa, respectively, are produced in 16 and 23% yield, respectively, when subjected to hydriodic acid hydrolysis, and (3) that black human hair contains approximately 99% eumelanin and 1% pheomelanin, brown and blond hair contain 95% eumelanin and 5% pheomelanin; and red hair contains 67% eumelanin and 33% pheomelanin. These data will allow deeper investigation into the relationship between melanin composition and drug incorporation into hair.

Chromatography, Liquid↗
PubMed2001

A 384-well solid-phase extraction for LC/MS/MS determination of methotrexate and its 7-hydroxy metabolite in human urine and plasma.

A solid-phase extraction procedure, in a 384-well format, has been developed for methotrexate and its primary metabolite, 7-hydroxymethotrexate, in human urine and plasma. This format has not been utilized previously for solid-phase extraction of drugs from biological fluids. The 384-well plates contained a C-18 stationary phase bonded to silica particles which are incorporated into a glass-fiber membrane. Methotrexate and 7-hydroxymethotrexate have been quantified across the curve range of 1 to 50 microg/mL and 50 to 1000 ng/mL, respectively, in urine and from 5 to 250 ng/mL and 5 to 100 ng/mL, respectively, in plasma. Both analytes are quantified by linear regression using 20-microL sample aliquots. Experiments to evaluate the influence of particle size, elution volume, and injection volume on signal intensity were conducted and are reported, along with the results of experiments examining cross contamination between wells. Recovery was determined to be > or = 95% from urine. Results from a run of 384 samples analyzed over a 14-h period indicate that 384-well SPE can be successfully utilized to increase analytical run sizes and sample throughput for LC/MS/MS determination of small drug molecules in biological samples.

Chromatography, Liquid↗
PubMed2001

Control method for integrity of continuous beds.

Monoliths are considered to be the latest version of stationary phases for protein chromatography. They are now becoming popular since they exhibit reduced peak broadening due to low mass transfer resistances. A weak point of monoliths may be an inhomogeneous bed, especially when charged groups are present during co-polymerization. This becomes apparent when a protein solution is loaded onto such a monolith. A biphasic breakthrough curve differing from the sigmoidal-shaped one, is observed. Two error functions were used to approximate the breakthrough curve. From these parameters an estimate of the fraction of flow passing through the homogeneously packed part of the bed as well as the inhomogeneously one was derived. This flow pattern was also confirmed by perfusing ferritin through an inhomogeneous monolith and comparing it to an intact one. Electron microscopy and mercury porosimetry did not indicate any abnormalities in the bed.

Chromatography, Liquid↗